+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation



Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation



Journal of Immunology 167(5): 2911-2920



Methotrexate (MTX), a folate antagonist, is a commonly used anti-inflammatory, antiproliferative, and immunosuppressive drug whose mode of action is not fully established. Due to the central role of NF-kappaB in these responses, we postulated that MTX must mediate its effects through suppression of NF-kappaB activation. We investigated the effects of MTX on NF-kappaB activation induced by TNF in Jurkat cells. The treatment of these cells with MTX suppressed TNF-induced NF-kappaB activation with optimum effects occurring at 10 microM MTX for 60 min. These effects were not restricted to Jurkat cells because other cell types were also inhibited. Besides TNF, MTX also suppressed the NF-kappaB activation induced by various other inflammatory stimuli. The suppression of TNF-induced NF-kappaB activation by MTX correlated with inhibition of IkappaBalpha degradation, suppression of IkappaBalpha phosphorylation, abrogation of IkappaBalpha kinase activation, and inhibition of NF-kappaB-dependent reporter gene expression. Because ecto 5' nucleotidase inhibitor (alpha,beta-methylene adenosine-5'-diphosphate) blocked the effect of MTX, adenosine mimicked the effect of MTX, and adenosine A2b receptor antagonist (3,7-dimethyl-1-propargylxanthine) reversed the inhibitory effect of MTX, we suggest that MTX suppresses NF-kappaB activation by releasing adenosine. A partial reversal of MTX-induced NF-kappaB suppression by thymidine and folinic acid indicates the role of the thymidylate synthase pathway also. Overall, our results clearly demonstrate that MTX suppresses NF-kappaB activation through the release of adenosine, which may contribute to the role of MTX in anti-inflammatory, immunomodulatory, and antiproliferative effects.

(PDF emailed within 1 workday: $29.90)

Accession: 046676742

Download citation: RISBibTeXText

PMID: 11509639


Related references

Taxol selectively blocks microtubule dependent NF-kappaB activation by phorbol ester via inhibition of IkappaBalpha phosphorylation and degradation. Oncogene 18(2): 495-505, 1999

Fas ligation induces NF-kappaB activation in HT-29 cells by phosphorylation of IkappaBalpha through a process dependent on NF-kappaB inducing kinase and IkappaB kinase beta and not through caspase dependent degradation of IkappaBalpha. Gastroenterology 122(4 Suppl 1): A 542, April, 2002

Methotrexate suppresses NF-kB activation through inhibition of IkBa phosphorylation and degradation. Journal of Immunology 167(5): 11-20, 2001

Methotrexate suppresses nuclear factor-kB activation through inhibition of IKBA phosphorylation and degradation. Journal of Interferon & Cytokine Research 24(Supplement 1): S 80, 2001

ChlaDub1 of Chlamydia trachomatis suppresses NF-kappaB activation and inhibits IkappaBalpha ubiquitination and degradation. Cellular Microbiology 10(9): 1879-1892, 2008

Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation. Journal of Biological Chemistry 272(48): 30129-30134, 1997

Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells. Blood 106(2): 641-649, 2005

Immunosuppressant FK506 activates NF-kappaB through the proteasome-mediated degradation of IkappaBalpha. Requirement for Ikappabalpha n-terminal phosphorylation but not ubiquitination sites. Journal of Biological Chemistry 274(49): 34657-34662, 1999

Inhibition of IkappaBalpha phosphorylation prevents glutamate-induced NF-kappaB activation and neuronal cell death. Acta Neurochirurgica. Supplement 93: 59-63, 2005

Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) suppresses NF-kappaB activation and NF-kappaB-regulated gene products through modulation of p65 and IkappaBalpha kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents. Journal of Biological Chemistry 281(25): 17023-17033, 2006

Inhibition of NF-kappaB by acute alcohol is common to monocyte activation through CD14/TLR4, IL-1- or TNF-receptor and it is independent of IkappaBalpha degradation. Journal of Endotoxin Research 8(3): 186-187, 2002

Deguelin, an Akt inhibitor, suppresses IkappaBalpha kinase activation leading to suppression of NF-kappaB-regulated gene expression, potentiation of apoptosis, and inhibition of cellular invasion. Journal of Immunology 177(8): 5612-5622, 2006

Preferential degradation of IkappaBalpha associated with NF-kappaB but reassociation of NF-kappaB with free IkappaBalpha before nuclear translocation. Biochemical Society Transactions 27(3): A94, 1999

Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation. Journal of Immunology 169(11): 6490-6497, 2002